Briefing
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.
A custom 30-gene melanoma sequencing panel for plasma ctDNA was tested in a cohort of 74 samples, covering driver mutations and alterations linked to treatment resistance.
- Design: Evidence level 3
- Assay: NGS